Coya Therapeutics, Inc entered into a Securities Purchase Agreement with certain accredited investors for 4,370,382 shares at a price of $6.06 per share of Common Stock for gross proceeds for $26,484,514 on December 5, 2023.The transaction is expected to close on December 11, 2023. The transaction included participation Wilbur Ross, former U.S. Secretary of Commerce and other existing institutional investors.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.91 USD | -2.94% | -9.39% | +6.75% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.75% | 120M | |
+67.53% | 63.85B | |
-0.77% | 41.83B | |
+45.66% | 40.65B | |
-10.72% | 27.12B | |
+13.30% | 26.52B | |
-22.79% | 18.69B | |
+4.70% | 12.73B | |
+24.10% | 12.11B | |
+27.41% | 12.07B |
- Stock Market
- Equities
- COYA Stock
- News Coya Therapeutics, Inc.
- Coya Therapeutics, Inc. announced that it expects to receive $26.484515 million in funding